| 摘要 |
The disclosure relates to method of treatment, dosage regimens, and medicaments comprising telaprevir for the treatment of hepatitis C virus in a patient infected with HIV. Also disclosed are methods of treatment, dosage regimens, and medicaments comprising telaprevir in combination with one or more of an interferon, ribavirin or anti-HIV agent. |
